Aaron D. Besterman

May 9, 2024 | medrxiv.org | Aaron D. Besterman |David Adams |Nicole Wong |Benjamin Schneider

S.M. acted as a paid consultant to Mirium Pharmaceuticals. All other authors declare no competing interests. A.D.B. was supported by an NIGMS T32 Medical Genetics Training Grant 2T32GM008243-31 and the UCLA Savant Fellowship in Neurodevelopmental Genetics. R.B.W. is supported by NICHD K23HD099275. R.B.W. and J.A.M-A.